ZeClinics

ZeClinics is a Biotech Contract Research Organization (CRO) and early-phase biopharmaceutical (PHARMA) company using zebrafish for high-throughput safety and efficacy screenings of novel chemical molecules, with pharmaceutical, environmental, chemical, cosmetic or nutritional potential. Granted with the maximum non-dilutive public funding opportunity for SMEs in Europe (SME Instrument Phase 2 category Supporting Innovative SMEs in the healthcare biotechnology sector with 1.87M) and several other private and public funding, ZeClinics offers advanced drug discovery assays, combining automated technologies, unique softwares of analysis and deep knowledge of zebrafish biology. We aim at challenging the traditional drug discovery pipeline by offering a cheap, fast...

Toxicology,oncology,drug discovery,zebrafish,neurobiology,crispr/cas9,disease models,phenotypical screening,and cardiovascular

Zeclinics operates in the Biotechnology research industry.

Zeclinics's revenue is 11m - 100m

Zeclinics has 11 - 50 employees.